Preclinical evaluation of immunogenicity, efficacy and safety of a recombinant plant-based SARS-CoV-2 RBD vaccine formulated with 3M-052-Alum adjuvant-Reference-Cited by-同舟云学术

Preclinical evaluation of immunogenicity, efficacy and safety of a recombinant plant-based SARS-CoV-2 RBD vaccine formulated with 3M-052-Alum adjuvant

Published:2023-04 Issue:17 Volume:41 Page:2781-2792
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Phoolcharoen Waranyoo,Shanmugaraj Balamurugan,Khorattanakulchai Narach,Sunyakumthorn Piyanate,Pichyangkul Sathit,Taepavarapruk Pornnarin,Praserthsee Wanlapa,Malaivijitnond Suchinda,Manopwisedjaroen Suwimon,Thitithanyanont Arunee,Srisutthisamphan Kanjana,Jongkaewwattana Anan,Tomai Mark,Fox Christopher B.,Taychakhoonavudh Suthira

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference48 articles.

1. Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2): An Emerging Zoonotic Respiratory Pathogen in Humans;Malla;J Pure Appl Microbiol,2020

2. Coronavirus disease 2019 (COVID-19) vaccine platforms: how novel platforms can prepare us for future pandemics: a narrative review;Lee;J Yeungnam Med Sci,2022

3. Contributions of the international plant science community to the fight against human infectious diseases – part 1: epidemic and pandemic diseases;Lobato Gómez;Plant Biotechnol J,2021

4. Plant Molecular Farming: A Viable Platform for Recombinant Biopharmaceutical;Shanmugaraj;Production. Plants,2020

5. Phase 1 randomized trial of a plant-derived virus-like particle vaccine for COVID-19;Ward;Nat Med,2021

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The impact of N-glycans on the immune response of plant-produced SARS-CoV-2 RBD-Fc proteins;Biotechnology Reports;2024-09

2. The Role of Mycobacterium indicus pranii in Sepsis Management: A Comprehensive Review of Clinical Outcomes and Therapeutic Potential;Cureus;2024-08-13

3. Nicotiana benthamiana as a potential source for producing anti-dengue virus D54 neutralizing therapeutic antibody;Biotechnology Reports;2024-06

4. Neutralizing activity of anti-respiratory syncytial virus monoclonal antibody produced in Nicotiana benthamiana;Human Vaccines & Immunotherapeutics;2024-03-20

5. Immunogenicity of a recombinant plant-produced respiratory syncytial virus F subunit vaccine in mice;Biotechnology Reports;2024-03